Lisa Hoban Tostanoski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immune Tolerance | 6 | 2023 | 2258 | 1.030 |
Why?
|
Antibodies, Neutralizing | 14 | 2024 | 1978 | 1.010 |
Why?
|
Adenoviridae | 4 | 2021 | 1099 | 0.760 |
Why?
|
Biocompatible Materials | 4 | 2021 | 1736 | 0.710 |
Why?
|
Bioengineering | 2 | 2017 | 99 | 0.680 |
Why?
|
Toll-Like Receptor 9 | 1 | 2019 | 212 | 0.610 |
Why?
|
Antibodies, Viral | 14 | 2024 | 3176 | 0.580 |
Why?
|
Macaca mulatta | 9 | 2022 | 2375 | 0.550 |
Why?
|
Viral Vaccines | 4 | 2021 | 636 | 0.490 |
Why?
|
Dendritic Cells | 8 | 2019 | 2725 | 0.430 |
Why?
|
Lymph Nodes | 4 | 2023 | 3474 | 0.410 |
Why?
|
Immunity | 1 | 2017 | 1012 | 0.380 |
Why?
|
Cricetinae | 4 | 2022 | 2472 | 0.380 |
Why?
|
Immunity, Cellular | 6 | 2021 | 1607 | 0.370 |
Why?
|
Multiple Sclerosis | 4 | 2019 | 3079 | 0.350 |
Why?
|
Epitopes | 1 | 2016 | 2571 | 0.350 |
Why?
|
Autoantigens | 4 | 2023 | 892 | 0.350 |
Why?
|
Vaccines, Synthetic | 3 | 2021 | 634 | 0.350 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3336 | 0.350 |
Why?
|
Pandemics | 5 | 2021 | 8388 | 0.340 |
Why?
|
Immunity, Humoral | 6 | 2021 | 598 | 0.320 |
Why?
|
Immunologic Factors | 1 | 2016 | 1580 | 0.290 |
Why?
|
Vaccination | 7 | 2024 | 3278 | 0.270 |
Why?
|
Autoimmunity | 4 | 2017 | 1349 | 0.270 |
Why?
|
Polymers | 3 | 2019 | 1621 | 0.260 |
Why?
|
Zeolites | 1 | 2024 | 8 | 0.250 |
Why?
|
Vaccines | 4 | 2023 | 822 | 0.240 |
Why?
|
Animals | 31 | 2023 | 168757 | 0.240 |
Why?
|
Mesocricetus | 2 | 2022 | 252 | 0.240 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.230 |
Why?
|
Disease Models, Animal | 9 | 2022 | 18029 | 0.230 |
Why?
|
Adenoviruses, Simian | 1 | 2021 | 14 | 0.210 |
Why?
|
Sirolimus | 3 | 2023 | 1564 | 0.200 |
Why?
|
Viral Load | 5 | 2020 | 3299 | 0.200 |
Why?
|
Adenoviridae Infections | 1 | 2021 | 96 | 0.190 |
Why?
|
Toll-Like Receptors | 3 | 2024 | 592 | 0.190 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2016 | 835 | 0.180 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2019 | 107 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2019 | 118 | 0.170 |
Why?
|
Vaccines, DNA | 1 | 2020 | 305 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3133 | 0.160 |
Why?
|
Laminin | 1 | 2019 | 419 | 0.160 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6386 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.150 |
Why?
|
Protein Engineering | 1 | 2021 | 540 | 0.150 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2023 | 745 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2017 | 2109 | 0.150 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2019 | 708 | 0.150 |
Why?
|
Mice, Inbred C57BL | 8 | 2019 | 21827 | 0.150 |
Why?
|
Signal Transduction | 3 | 2019 | 23403 | 0.150 |
Why?
|
Immunotherapy | 3 | 2017 | 4445 | 0.150 |
Why?
|
Peptide Nucleic Acids | 1 | 2016 | 25 | 0.140 |
Why?
|
T-Lymphocytes | 6 | 2021 | 10180 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Drug Delivery Systems | 3 | 2021 | 2219 | 0.140 |
Why?
|
Antigens | 3 | 2017 | 1466 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2019 | 4386 | 0.130 |
Why?
|
Cytokines | 4 | 2019 | 7322 | 0.130 |
Why?
|
Benzopyrans | 1 | 2015 | 64 | 0.130 |
Why?
|
Delayed-Action Preparations | 2 | 2017 | 968 | 0.130 |
Why?
|
Fetal Blood | 1 | 2021 | 1318 | 0.120 |
Why?
|
Mice | 13 | 2023 | 81183 | 0.120 |
Why?
|
Particle Size | 2 | 2016 | 1642 | 0.120 |
Why?
|
Electrolytes | 1 | 2015 | 282 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2021 | 768 | 0.120 |
Why?
|
Genetic Vectors | 2 | 2021 | 3420 | 0.120 |
Why?
|
Adjuvants, Immunologic | 4 | 2024 | 1000 | 0.120 |
Why?
|
Microspheres | 1 | 2016 | 777 | 0.120 |
Why?
|
Injections | 1 | 2016 | 840 | 0.110 |
Why?
|
Antigen Presentation | 2 | 2015 | 1284 | 0.110 |
Why?
|
Myelin Sheath | 1 | 2016 | 652 | 0.110 |
Why?
|
Gold | 1 | 2015 | 484 | 0.100 |
Why?
|
Kinetics | 1 | 2019 | 6473 | 0.100 |
Why?
|
Metal Nanoparticles | 1 | 2015 | 405 | 0.090 |
Why?
|
Phenotype | 2 | 2019 | 16365 | 0.090 |
Why?
|
Immunologic Memory | 3 | 2021 | 1348 | 0.090 |
Why?
|
Cross Reactions | 2 | 2021 | 841 | 0.090 |
Why?
|
Central Nervous System | 1 | 2016 | 1357 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2133 | 0.080 |
Why?
|
Humans | 21 | 2024 | 744343 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1341 | 0.080 |
Why?
|
Nanoparticles | 2 | 2021 | 1905 | 0.080 |
Why?
|
Cell Line | 2 | 2019 | 15997 | 0.080 |
Why?
|
Adoptive Transfer | 2 | 2020 | 844 | 0.080 |
Why?
|
Nasal Mucosa | 2 | 2020 | 373 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2021 | 1035 | 0.070 |
Why?
|
Inflammation | 2 | 2017 | 10638 | 0.070 |
Why?
|
Female | 15 | 2021 | 380194 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4479 | 0.070 |
Why?
|
Polyglycolic Acid | 2 | 2017 | 407 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4149 | 0.060 |
Why?
|
Virus Replication | 2 | 2021 | 2534 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.050 |
Why?
|
Immune Sera | 1 | 2022 | 641 | 0.050 |
Why?
|
Saccharomycetales | 1 | 2021 | 67 | 0.050 |
Why?
|
Lactic Acid | 2 | 2017 | 1133 | 0.050 |
Why?
|
Endosomes | 1 | 2024 | 520 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2021 | 168 | 0.050 |
Why?
|
Weight Loss | 2 | 2022 | 2622 | 0.050 |
Why?
|
Male | 10 | 2021 | 350118 | 0.040 |
Why?
|
Primates | 1 | 2022 | 545 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2022 | 4560 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2016 | 11483 | 0.040 |
Why?
|
Vero Cells | 1 | 2019 | 485 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 541 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 500 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2020 | 340 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1333 | 0.040 |
Why?
|
Nose | 1 | 2021 | 509 | 0.040 |
Why?
|
Immunoassay | 1 | 2021 | 752 | 0.040 |
Why?
|
Liposomes | 1 | 2021 | 759 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2023 | 13033 | 0.040 |
Why?
|
Cues | 1 | 2021 | 873 | 0.030 |
Why?
|
Ovalbumin | 1 | 2017 | 719 | 0.030 |
Why?
|
Nucleic Acids | 1 | 2016 | 182 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1836 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 2014 | 134 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 561 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9734 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 4011 | 0.030 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2015 | 211 | 0.030 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2014 | 205 | 0.030 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2014 | 194 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6114 | 0.030 |
Why?
|
Lung | 2 | 2022 | 9856 | 0.030 |
Why?
|
Phosphatidylcholines | 1 | 2014 | 411 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 808 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16689 | 0.030 |
Why?
|
Models, Molecular | 1 | 2021 | 5456 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56430 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2540 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10481 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 19229 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9386 | 0.020 |
Why?
|
Spleen | 1 | 2015 | 2362 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1182 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 21683 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4665 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2541 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 2988 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12026 | 0.020 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4397 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2019 | 3110 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 14557 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5097 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 213383 | 0.010 |
Why?
|
Peptides | 1 | 2015 | 4409 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7880 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85781 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|